Annual General Meeting of Endomines AB (publ) on 20 April 2017

The Annual General Meeting (the “AGM”) of shareholders of Endomines AB (publ) was held on 20 April 2017.

Appropriation of Endomines AB’s (publ) loss and discharge from liability for members of the Board of Directors and the CEO
The AGM resolved to adopt the Profit and Loss Statement and the Balance Sheet for the parent company as well as the Consolidated Profit and Loss Statement and the Consolidated Balance Sheet for the Group for 2016. The AGM resolved that no dividend should be paid and that the company’s result should be disposed so that SEK -35,578,621 shall be carried forward. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2016.

Board of Directors
The AGM resolved that the Board of Directors should consist of five members. Staffan Simberg, Stefan Månsson, Rauno Pitkänen, and Ann Zetterberg Littorin were re-elected as members of the Board of Directors, and Mikael Mattsson was elected as new member of the Board of Directors. In addition, Staffan Simberg was re-elected as chairman of the Board of Directors.

Remuneration to the board of directors
The AGM further resolved that the yearly fees shall be SEK 325,000 to the chairman of the Board of Directors and SEK 175,000 to each of the non-employed members of the Board of Directors. It was further resolved that committee work fees shall be SEK 25,000 to each member of the Remuneration Committee, Audit Committee and Technique and Security Committee and SEK 50,000 to the chairman of the Audit Committee.

Guidelines for remuneration to senior executives
The AGM resolved to approve to Board of Directors’ proposal for guidelines for remuneration to senior executives.

Authorization for the Board of Directors to resolve on new issue of shares, warrants and convertibles
The AGM resolved to authorize the Board of Directors during the period up to the next Annual General Meeting to, on one or several occasions, resolve on the issuance of new shares, warrants and/or convertibles with or without deviation from the shareholders’ pre-emption right, through payment with cash, with non-cash consideration or set-off.

For further information please contact:
Markus Ekberg, CEO of Endomines AB, tel. +358 40 706 48 50
___________________________________________________________________________________________

Endomines AB (publ) discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08:45 CEST on 21 April 2017.
___________________________________________________________________________________________

About Endomines:
Endomines is a gold concentrate producer with mining, development, and exploration operations in Eastern Finland along the 40 kilometer long Karelian Gold Line. Through various regulatory approvals, Endomines controls the exploration rights to this entire area. Endomines vision is to participate in the future structural transformation and consolidation of the Nordic mining industry. The Company may therefore be involved in acquisitions of interesting deposits or companies, should such opportunities arise.

The shares trade on Nasdaq Stockholm (ENDO) and Nasdaq Helsinki (ENDOM).

Tags: